Dr. Richard Burt of Northwestern University has been doing cutting edge research on the use of stem cells for autoimmune disorders for more than a decade. The core idea behind the work that Burt and other research teams are doing is that stem cells may have revolutionary potential to somehow counteract the autoimmunity that causes […]
Burt Northwestern Stem Cell MS Trial Part 1: Big Promise & Tough Questions Read More »
There is a growing trend of apparently unhappy patients suing stem cell clinics, which have faced more lawsuits recently and some of these cases are proposed class action suits that could have much broader impact. The latest case is against San Diego-based Stemgenex, a clinic that has claimed amongst other things that it can treat numerous diverse afflictions and that
Stem cell clinic lawsuits proliferate with latest against Stemgenex Read More »
Concerns over stem cell clinics allegedly causing blindness or other vision problems have been increasing in 2016. If this is in fact happening, the extra sad part of this is that some clinics have claimed that they are doing the opposite: improving vision in patients. What are the concerns? Earlier this year a publicly-traded stem
2nd lawsuit alleging a U.S. stem cell clinic caused blindness Read More »
I often am asked if there are ongoing or possible upcoming lawsuits against stem cell clinics. Doing periodic searches such as on Google is one way to learn more about whether there are stem cell legal cases out there. Recently I did such searches for a variety of terms including “stem cell lawsuit” and “stem
Possible class action lawsuit against stem cell clinics Read More »
There’s a growing trend whereby patients have to pay to be in a clinical trial. This is now widely referred to as “pay-to-play”. Proponents of this idea point toward potential benefits in the form of patients gaining access to innovative therapies. They also argue that this approach provides a much-needed funding mechanism for the trials
Poll: How do you feel about ‘pay-to-play’ clinical trials? Read More »
By Heather Main This year I will be attending the World Stem Cell Summit for the first time (see @WSCSummit on Twitter). I was surprised when I looked at the program and recognized so few of the names of speakers; which made me question what this event was about, if not focused on stem cell research.
Good reasons to go to the World Stem Cell Summit Read More »
We hear so much about exciting potential stem cell therapies, but what about stem cell treatment cost? Some of these “therapies” are rigorously evaluated ones in the FDA clinical trial pipeline and others are available right now mainly through predatory stem cell clinics. Earlier this year I posted about the cost of the offerings of
Stem cell treatment cost 2.0: legit therapy Read More »
ISSCR Chat By Michael Cea Jeanne Loring of the Scripps Research Institute in La Jolla, California kindly sat down with me at the ISSCR annual meeting for a broad discussion of her history, views on the field and developments in the science. I found Jeanne a refreshing character, as I did a number of others I was
Michael Cea ISSCR chat with Jeanne Loring on stem cell field Read More »
Masayo Takahashi (高橋 政代) on IPSC Trial for Macular Degeneration By Michael Cea Stem Cell Analyst & Advocate (editor’s note: piece was originally posted on Michael’s blog here; follow Michael on Twitter @msemporda) Masayo Takahashi interview Having followed closely the developments in programs using pluripotent based therapeutics I was fortunate during ISSCR2015 to have the opportunity to
Masayo Takahashi (高橋 政代) on IPSC Trial for Vision Read More »
The idea that we could bioengineer new human body parts to replace old, faulty ones is exciting, and such parts could include limbs, digits, or even entire organs. Such replacements might be produced using stem cells, 3-D printers, and other rapidly evolving, cutting edge technologies. Sci-fi is becoming a reality. Remember in Star Wars when
Will bioengineered body parts cost an arm and a leg? Read More »